
|Articles|June 6, 2017
Certara Launches CODEx to Inform Drug Development Decisions
Advertisement
Certara®, provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, launched its Clinical Outcomes Database Explorer (CODEx). It is an intuitive, web platform helping drug development teams visualize, explore, analyze, and communicate content from Certara's Clinical Trial Outcomes Databases, and streamline the analysis of therapeutic area-specific literature data to assess a new drug candidate's probability of regulatory and commercial success.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
3
ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD
4
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
5




